Il programma integrale del convegno svoltosi a Brussels ad aprile 2014, al quale ha partecipato Luigi Angrisani, nominato l'anno scorso Presidente dell'IFSO.
Professor Luigi Angrisani - rassegna stampa sicobLuigi Angrisani
Press Review relativa all'aumento di persone con problemi di obesità in Italia. Il Professor Angrisani si occupa dei pazienti con questa patologia proponendo la chirurgia bariatrica.
The DG Research workshop "From Systems Biology to Systems Medicine” report is now available. It is the unique opportunity to discover the 3 best practices and to anticipate the future European Research programs calls
Professor Luigi Angrisani - rassegna stampa sicobLuigi Angrisani
Press Review relativa all'aumento di persone con problemi di obesità in Italia. Il Professor Angrisani si occupa dei pazienti con questa patologia proponendo la chirurgia bariatrica.
The DG Research workshop "From Systems Biology to Systems Medicine” report is now available. It is the unique opportunity to discover the 3 best practices and to anticipate the future European Research programs calls
Klose lymphedema conference 2011 faculty and programklosetraining
We are honored to present Prof. Ethel Földi, MD as our Keynote Speaker. Prof. Földi is an internationally recognized authority on clinical lymphedema and lymphatic disorders. She serves as the Medical Director at the world-renowned Földi Clinic, specializing in the diagnosis and treatment of patients with lymphedema. Currently, Prof. Földi is the president of the Society of German-speaking lymphologists and a member of the International Advisory Committee to the National Lymphedema Network (NLN). She is also a past-President of the International Society of Lymphology (ISL).
Professionals and families from across Europe will be attending the Alstrom Syndrome UK Scientific Symposium on the 6th October 2017 in Birmingham, UK. Bringing together researchers, clinicians, professionals and families to discuss rare disease research, clinical developments and an opportunity to network with like-minded professionals. The agenda for this unique event is now available and further information can be found via the ASUK website http://www.alstrom.org.uk/ASUK-conference/
Big data: how it will help us?
The goal of this summit is to combine the different perspectives of data scientists, healthcare professionals, patients and governance to find the much- needed consensus for the next generation of healthcare systems. Join us and share your views and experience.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
More Related Content
Similar to Prof Luigi Angrisani - Final program Brussels April 2014
Klose lymphedema conference 2011 faculty and programklosetraining
We are honored to present Prof. Ethel Földi, MD as our Keynote Speaker. Prof. Földi is an internationally recognized authority on clinical lymphedema and lymphatic disorders. She serves as the Medical Director at the world-renowned Földi Clinic, specializing in the diagnosis and treatment of patients with lymphedema. Currently, Prof. Földi is the president of the Society of German-speaking lymphologists and a member of the International Advisory Committee to the National Lymphedema Network (NLN). She is also a past-President of the International Society of Lymphology (ISL).
Professionals and families from across Europe will be attending the Alstrom Syndrome UK Scientific Symposium on the 6th October 2017 in Birmingham, UK. Bringing together researchers, clinicians, professionals and families to discuss rare disease research, clinical developments and an opportunity to network with like-minded professionals. The agenda for this unique event is now available and further information can be found via the ASUK website http://www.alstrom.org.uk/ASUK-conference/
Big data: how it will help us?
The goal of this summit is to combine the different perspectives of data scientists, healthcare professionals, patients and governance to find the much- needed consensus for the next generation of healthcare systems. Join us and share your views and experience.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Prof Luigi Angrisani - Final program Brussels April 2014
1. 1
PRELIMINARY
PROGRAM
WEDNESDAY
30
APRIL
2014
08:00-‐18:00
Registration
&
Information
desk
WEDNESDAY
30
APRIL
2014
08:30
-‐
13:30
08:30
–
13:30
Overview
Program
3rd
European
Obesity
Medico-‐Surgical
Workshop
Metabolic
Surgery:
Guidelines
and
Clinical
Implications
(ARC)
ARC
3rd
European
Obesity
Medico-‐Surgical
Workshop
A
formal
satellite
of
IFSO-‐EC
congress
2014
Metabolic
Surgery:
Guidelines
and
Clinical
Implications
08:30-‐13:30
Jointly
organized
by
IFSO-‐EC
and
EASO
Organized
by
IFSO-‐EC:
Luc
Lemmens
(Belgium),
Yuri
Yashkov
(Russia),
Rudolf
Weiner
(Germany),
Alberic
Fiennes
(UK),
Martin
Fried
(Czech
Republic)
EASO:
Gema
Frühbeck
(Spain)
-‐
President,
Euan
Woodward
(UK)
-‐
Executive
Director,
Volkan
Yumuk
(UK)
-‐
OMTF
Chair,
Jean-‐Michel
Oppert
(Belgium)
-‐
Past
president,
Hermann
Toplak
(Austria)
-‐
President
elect
Moderators:
Jean-‐Michel
Oppert
(Belgium),
Luc
Lemmens
(Belgium)
08:30
Welcome
Luc
Lemmens
(Belgium)
Introduction
and
Overview
Jean-‐Michel
Oppert
(Belgium)
09:00
Keynote
Presentation
1
Who
for
metabolic
surgery?
Physician’s/
diabetologist’s
view
Luc
Van
Gaal
(Belgium)
09:30
Keynote
Presentation
2
Who
for
metabolic
surgery?
Surgeon´s
view
Luigi
Angrisani
(Italy)
09:50
Discussion
10:00
–
10:30
Coffee
break
Moderators:
Martin
Fried
(Czech
Republic),
Volkan
Yumuk
(UK)
10:30
-‐
11:30
Group
Session
1
2. 2
Who
for
metabolic
surgery?
Psychologist´s
view
(contra-‐indications/eating
disorders
questions,
psychopathologies
/motivation…)
Jitka
Herlesova
(Czech
Republic)
Samantha
Scholtz
(UK)
11:30
Keynote
Presentation
3
Management
of
diabetes
after
metabolic
surgery
Bernhard
Ludvik
(Austria)
11:50
Keynote
Presentation
4
Myths
in
bariatric
surgery
Lee
Kaplan
(USA)
12:30
–
13:30
Networking
Lunch
3. 3
WEDNESDAY
30
APRIL
2014
13:30
-‐
20:30
13:30
–
17:30
Overview
Parallel
Sessions
15:30-‐16:00:
Coffee
break
European
Obesity
Medico-‐Surgical
Workshop
(ARC)
International
Bariatric
Club
Symposium
(Hall
300)
13:30
–
17:30
Overview
Postgraduate
Courses
15:00-‐15:30:
Coffee
break
Postgraduate
course:
Sleeve
Gastrectomy
(Studio)
Postgraduate
course:
Reduced
Port
Surgery
(Studio)
Postgraduate
course:
Gastric
Bypass
(Studio)
18:00
–
20:30
Overview
Plenary
Program
Opening
Ceremony
(Copper
Room)
Get-‐Together
Reception
(Exhibition
hall)
4. 4
Program
in
detail
-‐
Parallel
Sessions
13:30-‐17:30
ARC
3rd
European
Obesity
Medico-‐Surgical
Workshop
A
formal
satellite
of
IFSO-‐EC
congress
2014
Metabolic
Surgery:
Guidelines
and
Clinical
Implications
13:30-‐17:30
Moderators:
Nicola
Scopinaro
(Italy),
Nicholas
Finer
(UK)
13:30
Keynote
Presentation
5
Who
for
metabolic
surgery?
Stratified
approach
surgeon’s
view
on
selection
of
different
metabolic
procedures
Gerhard
Prager
(Austria)
13:50
Keynote
Presentation
6
Who
for
metabolic
surgery?
Stratified
approach
physician´s
view
on
selection
of
different
metabolic
procedures
John
Wilding
(UK)
14:10
Discussion
14:30
-‐
15:30
Group
Session
2
Who
for
metabolic
surgery
–
Anesthesiologist´s
view
Ashish
Sinha
(USA)
+
Jan
Mulier
(Belgium)
15:30
-‐
16:00
Coffee
break
Moderators:
Alberic
Fiennes
(UK),
Javier
Salvador
(Spain)
16:00
Keynote
Presentation
7
Who
for
metabolic
surgery?
Basic
research
Elen
Blaak
(The
Netherlands)
16:30
Keynote
Presentation
8
Collaboration
between
physicians,
surgeons
and
governments
in
combating
the
epidemic
of
obesity
Jonathan
Valabhji
(UK)
17:00
Summing
Up
Martin
Fried
(Czech
Republic)
&
Volkan
Yumuk
(UK)
17:30
Close
5. 5
Hall
300
9th
International
Bariatric
Club
Symposium
13:30-‐17:30
13:30
Welcome
Luc
Lemmens
(Belgium),
President
of
the
6th
IFSO-‐EC
Congress
Introduction
Cynthia-‐Michelle
Borg
(UK)
Update
on
Future
IBC
symposia/website/journal
13:40
-‐
14:20
Keynote
lectures
Chairmen:
Luigi
Angrisani
(Italy),
Rudolf
Weiner
(Germany)
13:40
Robotic
bariatric
surgery
update
Ramon
Vilallonga
(Spain)
13:55
Discussion
14:00
Endoluminal
management
of
weight
regain
after
primary
bariatric
surgery
George
Eid
(USA)
14:15
Discussion
14:20
-‐
15:20
Debates
14.20
Staple
line
reinforcement
should
always
be
used
when
performing
sleeve
gastrectomy
Pro:
Michel
Gagner
(Canada)
Against:
Catalin
Copaescu
(Romania)
Moderator:
Surendra
Ugale
(India)
14:40
Audience
participation
and
vote
14:50
Malabsorptive
bariatric
surgeries
will
be
obsolete
in
10
years
time
Pro:
Martin
Freid
(Czech
Republic)
Against:
Antonio
Torres
Garcia
(Spain)
Moderator:
Jacques
Himpens
(Belgium)
15:10
Audience
participation
and
vote
15:20
-‐
15:50
Coffee
break
15:50
-‐
16:50
Expert
panel
discussion
Expert
Panel
Members:
Luigi
Angrisani,
Jean-‐Marc
Chevallier,
Catalin
Copaescu,
Evangelos
Efthimiou,
George
Eid,
Jacques
Himpens,
Antonio
Torres
Garcia,
Surendra
Ugale,
Rudolf
Weiner
15:50
1.
Leader:
George
Eid
(USA)
The
role
of
the
adjustable
band
in
revisional
surgery
16:10
2.
Leader:
Evangelos
Efthimiou
(UK)
Investigation
and
management
of
extreme
weight
loss
after
gastric
bypass
16:30
3.
Leader:
Catalin
Copaescu
(Romania)
Ileal
interposition
–
is
there
a
future
for
this
procedure?
16:50
-‐
17:20
2
interesting
case
discussions
from
IBC
FB
page
Leader:
Marius
Nedelcu
(France)
6. 6
Program
in
detail
-‐
Postgraduate
Courses
13:30-‐17:30
Studio
Postgraduate
course:
Sleeve
Gastrectomy
13:30-‐17:30
Chairman:
Jean
Closset
(Belgium)
Moderators:
Michel
Gagner
(Canada),
David
Nocca
(France),
Konrad
Karcz
(Germany),
Etienne
Van
Vyve
(Belgium)
13:30
-‐
15:00
Technique,
How
I
do
a
sleeve
Gastrectomy
?
For
which
patient?
Interactive
technical
session.
Each
step
of
the
procedure
and
each
specific
indication
will
be
presented
with
a
few
slides
and,
or
a
short
video,
and
then,
discussed
with
experts,
moderators
and
participants.
Place
of
first
firing
from
the
pylorus.
Last
firing
Do
we
need
a
bougie
to
size
the
sleeve?
Which
optimal
size?
Staple
heights
Reinforcement
of
staple
line
Oversew?
Buttressing
materials?
Drainage
Closure
of
diaphragmatic
crus
Reflux
and
Sleeve,
patient
with
GERD,
Barrett
Specific
indications:
Inflammatory
bowel
diseases,
Candidates
for
liver
or
kidney
transplatation,
Giant
Hernia,
Patient
with
high
ASA
score,
Adolescent
or
Eldery
morbidly
obese
patients,
Robotic
or
reduced
ports
surgery.
15:00
-‐15:30
Coffee
break
15:30
Postoperative
complications
and
management
of
complications
David
Nocca
(France)
16:15
-‐
17:30
Sleeve
gastrectomy
and
weight
regain
16:15
How
to
avoid
weight
regain?
Konrad
Karcz
(Germany)
16:45
What
can
I
do
in
case
of
weight
regain
after
Sleeve
gastrectomy?
Michel
Gagner
(Canada)
17:15
Round
table
7. 7
Studio
Postgraduate
course:
Reduced
Port
Surgery
13:30-‐17:30
Chairman:
Roberto
Tacchino
(Italy)
Moderators:
Denis
Pitot
(Belgium),
Jean
Louis
Allé
(Belgium),
Jan
Willem
Greve
(The
Netherlands)
13:30
SILS:
Sense
or
Non-‐Sense?
Who
for
SILS
Giovanni
Dapri
(Belgium)
13:50
SILS
or
Reduced
Ports?
Santi
Azagra
(Luxembourg)
14:10
Cost
effectiveness
of
SILS
approach
in
bariatric
surgery
Roberto
Tacchino
(Italy)
14:30
How
I
do
a
SILS
sleeve
Denis
Pitot
(Belgium)
15:00-‐15:30
Coffee
break
15:30
How
I
do
a
SILS
GBP
Jean
Louis
Allé
(Belgium)
15:50
How
I
do
a
SILS
MGBP
Roberto
Tacchino
(Italy)
16:10
How
I
do
a
Spider
GBP
Michel
Gagner
(Canada)
16:30
How
I
do
a
reduced
port
GBP
Santi
Azagra
(Luxembourg)
16:50
How
I
do
a
Robotic
GBP.
Robotics
in
SILS?
Carlos
Vaz
(Portugal)
17:10
How
I
do
a
SILS
sleeve
to
GBP
conversion?
Praveen
Raj
(India)
Studio
Postgraduate
course:
Gastric
Bypass
13:30-‐17:30
Chairman:
Bruno
Dillemans
(Belgium)
Moderators:
Raul
Rosenthal
(USA),
Michel
Suter
(Switzerland),
Marco
Anselmino
(Italy)
13:30
The
positioning
of
the
RNY
Gastric
Bypass
worldwide
Raul
Rosenthal
(USA)
13:40
-‐
14:50
What
is
the
perfect
RNY
Gastric
Bypass?
Technical
Aspects
13:40
Defining
length/size
of
gastric
pouch
and
loops.
Martine
Goergen
(Luxembourg)
13:50
Gastro
Jejunostomy:
Circular
Faki
Akin
(Turkey)
14:00
Gastro
Jejunostomy:
Linear
Thierry
Lafullarde
(Belgium)
14:10
Gastro
Jejunostomy:
handsewn
Yves
Van
Nieuwenhove
(Belgium)
14:20
The
Jejuno
jejunal
anastomosis:
handsewn
or
stapled?
Marco
Anselmino
(Italy)
8. 8
14:30
Closure
of
the
meso
gaps
Mehrdad
Biglari
(Belgium)
14:40
Complete
standardization
of
the
procedure
Bruno
Dillemans
(Belgium)
14:50
-‐
15:10
Tips
&
Tricks
in
a
conversional
RNY
Gastric
Bypass
14:50
From
Band/VBG
to
gastric
bypass
Michel
Suter
(Switzerland)
15:00
Resizing
the
pouch
Jean
Closset
(Belgium)
15:10
-‐
15:40
Coffee
Break
15:40
-‐
16:20
How
I
prevent
&
treat
complications
after
RNY
Gastric
Bypass
Acute:
15:40
Leak
Marco
Anselmino
(Italy)
15:50
Bleeding
Sebastiaan
Van
Cauwenberge
(Belgium)
Chronic:
16:00
Marginal
Ulcer
Bart
A.
van
Wagensveld
(The
Netherlands)
16:10
Internal
herniation
Bert
Deylgat
(Belgium)
16:20
The
rationale
of
banding
a
RNY
gastric
bypass
Luc
Lemmens
(Belgium)
16:30
Fast
Track
RNY
Gastric
Bypass
Maurits
de
Brauw
(The
Netherlands)
16:40
-‐
17:30
The
Omega
Loop
Gastric
Bypass
16:40
Past,
present
&
future
Jean-‐Marc
Chevallier
(France)
Surgical
Tips
&
Tricks
16:50
Gastric
pouch
construction
Jean-‐Marc
Chevallier
(France)
17:00
The
gastro
jejunostomy
Jacques
Himpens
(Belgium)
17:10
Round
table
debate
Will
the
Omega
Loop
ever
beat
the
RNY
Gastric
Bypass?
Jean-‐Marc
Chevallier
(France),
Raul
Rosenthal
(USA),
Michel
Suter
(Switzerland),
Pradeep
Chowbey
(India),
Bruno
Dillemans
(Belgium)
Program
in
detail
-‐
Plenary
Program
18:00-‐20:30
Opening
Ceremony
(Copper
Room)
Get-‐Together
Reception
(Exhibition
hall)
9. 9
THURSDAY
1
MAY
2014
08:00-‐18:30
Registration
&
Information
desk
THURSDAY
1
MAY
2014
09:00-‐14:00
08:45–
10:00
Overview
Plenary
Session
Opening
Ceremony
IFSO-‐EC
2014
Congress
(Copper
Room)
Opening
Session:
Bariatric
and
/
or
Metabolic
Surgery
(Copper
Room)
10:00-‐10:30:
Coffee
break
10:30
–
12:30
Overview
Parallel
Sessions
Malabsorption
Surgery:
BPD
&
BPD-‐DS
(Copper
Room)
Functional
Problems
after
Bariatric
Surgery
(Silver
Room)
Restrictive
Surgery
(ARC)
Nurses
&
Allied
Health
Care
Professionals
-‐
Part
1
(Hall
300)
Corporate
Round
Table:
Bariatric
Solutions
(Room
201)
10:30
–
12:30
Midday
Program
• Selected
ePoster
Presentations
(Exhibition
hall)
• ePoster
Viewing
(Exhibition
hall)
• Corporate
Symposium:
Ethicon
-‐
a
Johnson
&
Johnson
Company
(Copper
Room)
10. 10
Program
in
detail
-‐
Plenary
Session
09:00-‐10:00
Copper
Room
Opening
Ceremony
IFSO-‐EC
2014
08:45-‐09:00
Welcome
addresses
• Luc
Lemmens,
president
IFSO-‐EC
2014
Congress
• Yuri
Yashkov,
president
IFSO-‐EC
• Luigi
Angrisani,
president
IFSO
Copper
Room
Opening
Session:
Bariatric
and
/
or
Metabolic
Surgery
09:00-‐10:00
Chairman:
Luc
Lemmens,
President
IFSO-‐EC
2014
Congress
09:00
70
years
of
evolution
in
bariatric
surgery
Henri
Buchwald
(USA)
09:20
From
bariatric
to
metabolic
surgery
Raul
Rosenthal
(USA)
09:40
Future
of
metabolic
surgery
François
Pattou
(France)
Program
in
detail
-‐
Parallel
Sessions
10:30-‐12:30
Copper
Room
Malabsorption
Surgery:
BPD
&
BPD-‐DS
10:30-‐12:30
Chairman:
Nicola
Scopinaro
(Italy)
Moderators:
Yuri
Yashkov
(Russia),
Jacques
Himpens
(Belgium)
10:30
Physiology
of
malabsorption
Nicola
Scopinaro
(Italy)
10:55
Technique
of
LBPD
Luc
Lemmens
(Belgium)
11:10
Technique
of
LDS:
One
or
two
stages
Jacques
Himpens
(Belgium)
11:25
Technique
of
SADI’S
Antonio
Torres
(Spain)
11:40
Long
term
metabolic
effects
of
malabsorption
surgery
Yuri
Yashkov
(Russia)
11:55
Long
term
complications
of
malabsorption
Surgery
Daniel
Krawczykowski
(France)
11. 11
12:10
O-‐001
Long
term
results
and
experience
with
laparoscopic
simplified
duodenal
switch
with
right
gastric
artery
ligation
Pujol
Gebelli
J.,
García
Ruiz
de
Gordejuela
A.,
Casajoana
Badía
A.,
Elvira
López
J.
(Spain)
12:20
O-‐002
Effects
of
bypass
distalization
on
weight
loss
after
prior
gastric
bypass
Feis
V.B.,
Kaijser
M.A.,
Apers
J.A.,
Totté
E.R.,
Emous
M.
(The
Netherlands)
Silver
Room
Functional
Problems
after
Bariatric
Surgery
10:30-‐12:30
Chairman:
Guy
Hubens
(Belgium)
Moderators:
Raul
Rosenthal
(USA),
Christine
Stier
(Germany)
10:30
Medication
malabsorption
Ann
Verhaegen
(Belgium)
10:45
Late
weight
regain
Guy
Hubens
(Belgium)
11:00
Dumping
Yves
Van
Nieuwenhove
(Belgium)
11:15
GERD
after
bariatric
surgery
Raul
Rosenthal
(USA)
11:30
Revisional
surgery
for
non-‐weight
related
indications
Scott
Shikora
(USA)
11:45
Marginal
ulcers
after
bariatric
surgery
Bart
A.
van
Wagensveld
(The
Netherlands)
12:00
O-‐003
Management
and
treatment
of
sphincter
of
Oddi
dysfunction
in
the
gastric
bypass
population
Opsomer
D.,
Valk
J.,
Gypen
B.,
Hendrickx
L.
(Belgium)
12:10
O-‐004
Increased
esophageal
exposure
to
weakly
acidic
reflux
after
laparoscopic
Roux-‐en-‐Y-‐
gastric
bypass
for
morbid
obesity
Toppino
M.,
Rebecchi
F.,
Allaix
M.E.,
Giaccone
C.,
Merlo
P.,
Morino
M.
(Italy)
12:20
O-‐005
A
less
known
complication
of
sleeve
gastrectomy:
esophageal
dilatation
with
esophagogastric
junction
effacement,
weight
gain
and
severe
reflux
Carmeli
I.,
Kashtan
H.,
Ben
David
M.,
Keidar
A.
(Israel)
ARC
Restrictive
Surgery
10:30-‐12:30
Chairman:
Luigi
Angrisani
(Italy)
Moderators:
Paul
O’Brien
(Australia),
Arijan
Luyten
(The
Netherlands),
Marc
Legrand
(Belgium)
10:30
Indications
for
purely
restrictive
surgery
in
2014
Jean-‐Marc
Chevallier
(France)
10:50
Clinical
trials
of
gastric
banding
for
diabetes
and
related
metabolic
disorders
Paul
O’Brien
(Australia)
11:10
Long-‐term
results
of
restrictive
surgery
Luigi
Angrisani
(Italy)
12. 12
11:30
Reflux
and
motility
disorders
after
restrictive
procedure
Karl
Miller
(Austria)
11:50
Bypass
after
band
leaving
the
band
in
place
Jan
Willem
Greve
(The
Netherlands)
12:10
O-‐006
Obalon
swallowable
intragastric
balloon
Genco
A.,
Maselli
R.,
Frangella
F.,
Casella
G.,
Leone
G.,
Redler
A.
(Italy)
12:20
O-‐007
How
I
do
it:
laparoscopic
adjustable
gastric
banding
mesh
port
site
fixation
Owers
C.E.,
Ackroyd
R.
(UK)
Hall
300
Nurses
&
Allied
Health
Care
Professionals
-‐
Part
1
10:30-‐12:30
Chairman:
Pradeep
Chowbey
(India)
Moderators:
Jean-‐Michel
Oppert
(France),
Marie
Barea
(Belgium),
Laurent
Kohnen
(Belgium)
10:30
Supplementation
of
vitamins
and
micronutrients
after
metabolic
surgery
Gerhard
Prager
(Austria)
10:45
Psychological
interventions
in
bariatric
and
obesity
clinics:
contribution
of
third
wave
psychotherapies
Emmanuelle
Hayward
(Belgium)
11:00
Psychological
factors
and
weight
loss
after
gastric
bypass
surgery:
do
we
have
some
predictors?
Barbara
Lembo
(Belgium)
11:15
Usefulness
of
the
BAROS
score
in
the
evaluation
of
primary
versus
revision
gastric
bypass
Julie
Navez
(Belgium)
11:30
Physical
activity
and
sedentary
behavior
after
bariatric
surgery
Jean
Michel
Oppert
(France)
11:45
Nutritional
management
after
bariatric
surgery
Severine
Ledoux
(France)
12:00
Importance
of
exercise
after
bariatric
surgery
Sanne
Stegen
(Belgium)
12:15
O-‐008
Three
years
durability
of
the
improvements
in
health-‐related
quality
of
life
observed
after
gastric
banding
Busetto
L.,
Mozzi
E.,
Schettino
A.,
Furbetta
F.,
Giardiello
C.,
Micheletto
G.,
Pilone
V.
(Italy)
Room
201
Corporate
Round
Table:
Bariatric
Solutions
11:30-‐12:30
13. 13
Program
in
detail
-‐
Midday
Program
12:30-‐14:00
Copper
Room
Corporate
Symposium:
Ethicon
-‐
Johnson
&
Johnson
Company
12:35-‐14:00
Exhibition
Hall
Selected
ePoster
Presentations
I
12:45-‐13:55
Chairmen:
Dany
Burnon
(Belgium)
&
Yuri
Yashkov
(Russia)
Each
presentation
will
take
5
minutes
1
P03
Pitfalls
in
diagnosing
internal
herniation
Geubbels
N.,
Roell
E.A.,
Acherman
Y.I.Z.,
Bruin
S.C.,
van
de
Laar
A.W.J.M.,
de
Brauw
L.M.
(The
Netherlands)
2
P11
Weight
loss
prior
to
bariatric
surgery
and
postoperative
complications.
Data
from
the
Scandinavian
Obesity
Registry
(SOREG)
Anderin
C.,
Gustafsson
O.U.,
Heijbel
N.,
Thorell
A.
(Sweden)
3
P18
Vitamin
b12
treatment
in
bariatric
patients
with
vitamin
b12
levels
between
140
and
200
nmol/L
Smelt
H.J.M.,
Nienhuijs
S.W.,
Said
M.,
Wezenbeek
M.R.,
Smulders
J.F.,
Boer
A.K.
(The
Netherlands)
4
P20
Does
closure
of
mensenteric
defects
with
clips
during
laparoscopic
gastric
bypass
prevent
internal
herniation
in
long-‐term
follow-‐up?
-‐
A
randomized
prospective
study
Kristensen
S.D.,
Naver
L.,
Jess
P.,
Floyd
A.K.
(Denmark)
5
P23
Changes
of
body
composition
among
normal,
overweight
and
morbid
obese
patients
after
tailored
one
anastomosis
gastric
bypass
(BAGUA):
influence
of
diabetes
and
metabolic
syndrome
García-‐Caballero
M.,
Reyes-‐Ortiz
A.,
Toval
J.A.,
García
M.,
Martínez-‐Moreno
J.M.,
García
A.,
Mínguez
A.,
Osorio
D.,
Mata
J.M.
(Spain)
6
P24
The
effect
of
bariatric
surgery
on
type
2
diabetes
mellitus:
laparoscopic
sleeve
gastrectomy
versus
laparoscopic
minigastric
bypass
Ozmen
M.M.,
Sahin
T.T.,
Moran
M.,
Gelecek
S.,
Isgenderova
S.,
Guldogan
E.,
Gundogdu
E.
(Turkey)
7
P30
Long
term
results
of
laparoscopic
Roux-‐en-‐Y
gastric
bypass
after
previous
laparoscopic
gastric
banding
procedure,
patients
ouctome
and
5
year
follow-‐up:
an
expert
centre
experience
Heyman
S.,
Gypen
B.,
Van
Sprundel
F.,
Hendrickx
L.,
Valk
J.
(Belgium)
8
P31
Long-‐term
effects
of
laparoscopic
Roux-‐en-‐y
gastric
bypass
on
diabetes
mellitus,
hypertension
and
dyslipidemia
in
morbidly
obese
patients
Schijns
W.,
Dogan
K.,
Homan
J.,
Betzel
B.,
Aarts
E.O.,
Ploeger
N.,
de
Boer
H.,
Aufenacker
T.J.,
van
Laarhoven
C.J.H.M.,
Janssen
I.M.C.,
Berends
F.J.
(The
Netherlands)
9
P35
Deficits
observed
after
biliopancreatic
diversion:
a
long-‐term
follow-‐up
study
Kotelnikova
L.,
Stepanov
R.,
Plaksin
S.
(Russia)
10
P36
Long
term
results
after
bariatric
surgery
in
super
obese
patients
with
BMI
over
53
Tzvetkov
I.G.,
Tzankov
G.D.
(UK)
11
P41
Esophageal
stenting
for
enteric
leaks
after
bariatric
surgery:
a
single
institution
experience
Vermeersch
G.,
Heyman
S.,
Moreels
T.,
Hubens
G.
(Belgium)
14. 14
12
P49
Gastric
bypass
surgery
-‐
Patient
experiences
of
psychosocial
and
physical
perspective
Karlsson
A.,
Nilsson
M.,
Holmstrom
J.,
Hedov
G.
(Sweden)
13
P51
Analysis
the
relative
prevalences
for
the
apolipoprotein
E
and
CIII
in
patients
with
obesity-‐related
phenotype
BMI
after
bariatric
surgery
Cagigas
J.C.,
Colsa
P.,
Ruiz
J.L.,
Estefanía
R.H.,
Ovejero
V.,
Cagigas
Roecker
P.,
Lamuño
D.G.,
Escalante
C.,
Ingelmo
A.
(Spain)
14
P52
Study
of
gen
OB
expression
and
relation
with
leptin
levels
after
vertical
banded
gastroplasty
(VBG)
with
analysys
the
prevalence
of
genetics
polimorphs
Cagigas
J.C.,
Colsa
P.,
Ruiz
J.L.,
Estefanía
R.H.,
Ovejero
V.,
Cagigas
Roecker
P.,
Lamuño
D.G.,
Escalante
C.,
Ingelmo
A.
(Spain)
15
P54
Personalized
laboratory
medicine
in
bariatric
surgery
–
Assessment
of
interpretation
and
efficacy
Bazuin
I.,
Houterman
S.,
Nienhuis
S.W.,
Smulders
J.F.,
Boer
A.K.
(The
Netherlands)
15. 15
THURSDAY
1
MAY
2014
14:00-‐18:30
14:00
–
15:30
Overview
Parallel
Sessions
Main
Session:
Gastric
Bypass
-‐
Part
1
(Copper
Room)
Session:
Redo-‐Surgery
(Silver
Room)
Session:
Sleeve
Gastrectomy
(ARC)
Nurses
&
Allied
Health
Care
Professionals
-‐
Part
2
(Hall
300)
15:30-‐16:00:
Coffee
break
16:00
–
17:30
Overview
Parallel
Sessions
Main
Session:
Gastric
Bypass
-‐
Part
2
(Copper
Room)
Video
Session
(Silver
Room)
Session:
Miscellaneous
(ARC)
Bariatric
Surgery
in
Adolescents
Dutch
Society
for
Metabolic
and
Bariatric
Surgery
(Hall
300)
17:35
–
18:35
Overview
Parallel
Sessions
Main
Session:
Gastric
Bypass
-‐
Match
of
the
day
(Copper
Room)
Session:
Long-‐Term
Results
(ARC)
Session:
Screening
&
Health
Aspects
(Hall
300)
18:35
–
19:35
Corporate
Symposium
:
Covidien
16. 16
Program
in
detail
-‐
Parallel
Sessions
14:00
–
15:30
Copper
Room
Gastric
Bypass
-‐
Part
1
14:00-‐15:30
Chairman:
Bruno
Dillemans
(Belgium)
Moderators:
Raul
Rosenthal
(USA),
Michel
Suter
(Switzerland),
Marco
Anselmino
(Italy)
14:00
Why
is
the
RNY
Gastric
Bypass
still
standing?
Michel
Suter
(Switzerland)
14:10
How
does
the
RNY
bypass
work?
All
about
the
unknown!
Gerhard
Prager
(Austria)
14:20
New
Surgical
technical
developments
14:20
Hand
sewn
closure
of
the
gastrojejunal
anastomosis
with
the
barbed
stitch:
3
years
experience
Santi
Azagra
(Luxembourg)
14:30
Closure
of
both
meso-‐gaps
with
staplers
Frits
Berends
(The
Netherlands)
14:40
Can
we
improve
the
long-‐term
results
14:40
Banding
the
RNY
gastric
bypass
Luc
Lemmens
(Belgium)
14:50
Tailoring
the
limb
lengths
of
the
RNY
gastric
bypass
Benoit
Navez
(Belgium)
15:00
When
is
the
RNY
gastric
bypass
superior
to
the
sleeve?
15:00
T2DM
/
Hypercholesterolemia
Pradeep
Chowbey
(India)
15:10
Conversional
procedure
(failed
band/VBG)
Raul
Rosenthal
(USA)
15:20
O-‐009
Laparoscopic
Roux-‐en-‐Y
gastric
bypass
and
concomitant
laparoscopic
abdominal
wall
hernia
repair
with
prosthetic
mesh
is
safe
and
feasible
Nagliati
C.,
Raje
D.,
Jambulingam
P.,
Whitelaw
D.,
Barreca
M.,
Jain
V.
(UK)
Silver
Room
Session:
Redo-‐Surgery
14:00-‐15:30
Chairman:
Sergio
Santoro
(Brazil)
Moderators:
Peter
Vases
(UK),
Keseva
Mannur
(UK),
John
Melissas
(Greece)
14:00
O-‐010
Similar
post
operative
safety
between
primary
versus
revisional
gastric
bypass
for
failed
gastric
banding
Thereaux
J.,
Veyrie
N.,
Barsamian
C.,
Corigliano
N.,
Beauchet
A.,
Poitou
C.,
Oppert
J.-‐M.,
Czernichow
S.,
Bouillot
J-‐L.
(France)
14:10
O-‐011
Conversion
of
failed
laparoscopic
adjustable
gastric
banding
to
Roux-‐en-‐Y
gastric
bypass
is
safe
as
a
single
step
procedure
Emous
M.,
Apers
J.A.
,
van
Beek
A.P.,
Totté
E.
(The
Netherlands)
14:20
O-‐012
Failed
adjustable
gastric
banding:
outcomes
of
conversion
to
laparoscopic
Roux-‐en-‐Y
gastric
bypass:
a
single-‐center,
single-‐surgeon
series
of
143
cases
Haenen
F.,
Gys
B.,
Gys
T.,
Lafullarde
T.
(Belgium)
17. 17
14:30
O-‐013
Outcomes
of
revisional
Omega
loop
gastric
bypass
after
failed
gastric
banding:
a
retrospective
study
of
879
patients
Genser
L.,
Soprani
A.,
Sibaud
0.,
Torcivia
A.,
Godfroy
J.,
Siksik
J.M.,
Hannoun
L.,
Cady
J.
(France)
14:40
O-‐014
Conversion
of
failed
gastric
banding
into
gastric
bypass
or
sleeve
gastrectomy
Kaufman
T.,
Carmeli
I.,
Kashtan
H.,
Keidar
A.
(Israel)
14:50
O-‐015
Primary
versus
revisional
laparoscopic
gastric
bypass
after
failed
restrictive
gastroplasty
:
long-‐term
comparative
results
Navez
J.,
Dardamanis
D.,
Thyssen
J.P.,
Navez
B.
(Belgium)
15:00
O-‐016
Laparoscopic
non-‐adjustable
band
placement
as
a
revisional
procedure
for
failed
Roux-‐
en-‐Y
gastric
bypass
Abdelgabar
A.,
Gypen
B.,
Valk
J.W.,
Van
Sprundel
F.,
Hendrickx
L.
(Belgium)
15:10
O-‐017
Re-‐do
bariatric
procedure
–
Position
of
laparo
scopic
gastric
plication
Fried
M.,
Dolezalova
K.
(Czech
Republic)
15:20
O-‐018
Neofundus
development
after
laparoscopic
sleeve
gastrectomy.
Is
fundectomy
safe
and
effective
as
revisional
surgery?
De
Angelis
F.,
Albanese
A.,
Rizzello
M.,
Iossa
A.,
Liguori
A.,
Avallone
M.,
Longo
F.,
Ruscio
S.,
Cavallaro
G.,
Foletto
M.,
Silecchia
G.
(Italy)
ARC
Session:
Sleeve
Gastrectomy
14:00-‐15:30
Chairman:
Abdulaziz
Al
Maazmi
Zaid
(UAE)
Moderators:
Lannoo
Matthias
(Belgium)
14:00
O-‐019
Motor
impulsivity
as
a
predictor
of
weight
loss
in
bariatric
patients
Kulendran
M.,
Lim
M.,
Zafar
N.,
Vlaev
I.,
Wingfield
L.R.,
Scholtz
S.,
Purkayastha
S.,
Darzi
A.
(UK)
14:10
O-‐020
Influence
of
different
age
groups
on
weight
loss
after
laparoscopic
sleeve
gastrectomy
Huang
Y.
(Taiwan)
14:20
O-‐021
Metabolic
effects
of
laparoscopic
sleeve
gastrectomy
Golomb
I.,
Ben
Yaakov
A.,
Kashtan
H.,
Keidar
A.
(Israel)
14:30
O-‐022
Comorbidity
resolution
and
growth
of
morbidly
obese
children
and
adolescents
undergoing
sleeve
gastrectomy
Alqahtani
A.,
Elahmedi
M.
(Saudi
Arabia)
14:40
O-‐023
Our
first
100
laparoscopic
sleeve
gastrectomy
as
day-‐case
surgery
(without
overnight
hospitalization)
Rebibo
L.,
Dhahri
A.,
Badaoui
R.,
Verhaeghe
P.,
Dupont
H.,
Regimbeau
J-‐M.
(France)
14:50
O-‐024
Partially
reversible
sleeve
gastrectomy:
the
result
of
500
cases
Fardoun
A.
(United
Arab
Emirates)
15:00
O-‐025
Laparoscopic
sleeve
gastrectomy
with
concomitant
hiatus
defect
repair:
simple
versus
mesh
reinforced
hiatoplasty
Iossa
A.,
Ruscio
S.,
De
Angelis
F.
Longo
F.,
Liguori
M.A.,
Avallone
M.,
Silecchia
G.
(Italy)
15:10
O-‐026
Simultaneous
covered
stent
and
double
pigtail
stent
as
treatment
of
large
gastric
fistula
orifice
after
sleeve
gastrectomy
Rebibo
L.,
Fumery
F.,
Dhahri
A.,
Brazier
F.,
Delcenserie
R.,
Regimbeau
J.-‐M.
(France)
15:20
O-‐027
Laparoscopic
sleeve
gastrectomy,
with
or
without
antrum
preservation
and
its
effects
on
food
tolerance,
body
composition
and
quality
of
life:
preliminary
results
Molina
A.,
Sabench
F.,
Hernández
M.,
Blanco
S.,
Bonada
A.,
Sánchez
A.,
Raga
E.,
Prieto
R.,
París
M.,
Muñoz
A.,
Del
Castillo
D.
(Spain)
18. 18
Hall
300
Nurses
&
Allied
Health
Care
Professionals
-‐
Part
2
14:00-‐15:30
Chairman:
Karl
Miller
(Austria)
Moderator:
Nicola
Scopinaro
(Italy),
Ruth
Trioen
(Belgium)
14:00
Fertility,
reproduction
and
pregnancy
after
obesity
surgery
Roland
Devlieger
(Belgium)
14:15
Pregnancy
and
bariatric/metabolic
surgery
Karl
Miller
(Austria)
14:30
Surgical
approach
of
type
2
diabetes:
from
bariatric
surgery
to
metabolic
surgery
André
J.
Scheen
(Belgium)
14:45
Dumping
and
hypoglycemia
after
gastric
bypass
surgery
Jean-‐Paul
Thissen
(Belgium)
15:00
What
you
should
know
about
aftercare
and
adjustment
Paul
O’Brien
(Australia)
15:15
Place
of
high
protein
diet
and
hepatic
volumetry
Etienne
Van
Vyve
&
Desislava
Germanova
(Belgium)
19. 19
Program
in
detail
-‐
Parallel
Sessions
16:00
–
17:30
Copper
Room
Gastric
Bypass
-‐
Part
2
16:00-‐17:30
Chairman:
Rudolf
Weiner
(Germany)
Moderators:
Juan
Pujol-‐Rafols
(Spain),
Karl
Miller
(Austria),
Benoit
Navez
(Belgium)
16:00
Endoluminal
techniques
Daniel
Blero
(Belgium)
16:15
Resizing
pouch/stoma
Antonio
Iannelli
(France)
16:30
Banding
the
pouch
Bruno
Dillemans
(Belgium)
16:45
Distalisation
of
RNY
Gastric
Bypass
Benoit
Navez
(Belgium)
17:00
Conversion
to
sleeve
Jacques
Himpens
(Belgium)
17:15
Long-‐term
results
after
redo
Martin
Thurnheer
(Switzerland)
Silver
Room
Video
Session
16:00-‐17:30
Chairman:
Marcello
Lucchese
(Italy)
Moderator:
Khaled
Gawdat
(Egypt),
Audun
Sirgudsson
(Iceland),
Thierry
Lafullarde
(Belgium)
O-‐028
SILS
–
Revisional
gastric
bypass
video-‐technique
Chelala
E.
(Belgium)
O-‐029
Laparoscopic
surgical
technique
of
an
adjustable
banded
Roux-‐en-‐Y
gastric
bypass
for
super
obese
patients
(body
mass
index
>
60kg/m²)
Van
Cleven
S.,
Dillemans
B.
(Belgium)
O-‐030
A
mirror
surgical
bariatric
procedure
Simonelli
V.,
Di
Campli
M.P.,
Pau
L.,
Loi
P.,
CLosset
J.
(Belgium)
O-‐031
Sleeved
gastric
bypass
–
A
new
technique
Ribeiro
R.,
Guerra
A.,
Manaças
L.,
Pereira
J.
(Portugal)
O-‐032
Fast
and
simplified
closing
of
the
mesenteric
defects
with
an
endoscopic
stapler
Van
Der
Fraenen
D.,
Deylgat
B.,
Dillemans
D.
(Belgium)
O-‐033
Total
reversal
of
Roux-‐en-‐y
gastric
bypass
technique
Altemyatt
S.,
Saber
M.
(Saudi
Arabia)
O-‐034
Complications
of
the
banded
gastric
bypass:
laparoscopic
revisions
of
three
different
complications
Valk
J.,
Gypen
B.,
Hendrickx
L.
Van
Sprundel
F.
(Belgium)
O-‐035
Endoscopic
treatment
of
common
bile
duct
stones
after
gastric
bypass
Allé
J.L.,
M’Roue
A.,
Charara
F.,
Dessily
M.
(Belgium)
O-‐036
Is
endoscopic
stenting
feasible
for
the
treatment
of
leaks
and
strictures
after
sleeve
gastrectomy
Taskin
H.E.,
Zengin
K.,
Tosun
Y.,
Taskin
M.
(Turkey)
20. 20
ARC
Session:
Miscellaneous
16:00-‐17:30
Chairman:
John
Melissas
(Greece)
Moderators:
De
Vogelaere
Kristel
(Belgium),
Sanjay
Agrawal
(UK)
16:00
O-‐037
Biliopancreatic
diversion
with
duodenal
switch
following
renal
transplantation
Golomb
I.
,
Winkler
J.,
Mor
E.,
Nesher
E.,
Keidar
A.
(Israel)
16:10
O-‐038
Scopinaro
and
biliopancreatic
diversion
with
duodenal
switch
as
revisional
bariatric
procedure
in
47
patients
Homan
J.,
van
Wageningen
B.,
Betzel
B.,
Aarts
E.O.,
Edwards
M.J.,
Janssen
I.M.C.,
Berends
F.J.
(The
Netherlands)
16:20
O-‐039
Excess
weight
loss
in
the
different
BMI-‐groups:
a
comparative
assessment
of
sleeve
gastrectomy
and
duodenal
switch
Yashkov
Y.,
Bordan
N.
(Russia)
16:30
O-‐040
Effect
of
weight
regain
on
the
glycaemic
control
in
diabetic
patients
submitted
to
BPD
with
BMI
below
35
Papadia
F.S.,
Longo
G.,
Terulla
A.,
Bobbio
C.,
Grossetti
F.,
Camerini
G.,
Scopinaro
N.
(Italy)
16:40
O-‐041
Experience
in
over
150
patients
with
the
EndoBarrier®/
duodenal-‐jejunal
bypass
liner
Betzel
B.,
Koehestanie
P.,
Aarts
E.O.,
Dogan
K.,
Homan
J.,
Janssen
I.M.C.,
Wahab
P.J.,
Groenen
M.J.M.,
Berends
F.J.
(The
Netherlands)
16:50
O-‐042
Frequency
and
management
of
complications
of
the
duodenal-‐jejunal
bypass
liner:
a
prospective
study
Betzel
B.,
Koehestanie
P.,
Aarts
E.O.,
Dogan
K.,
Homan
J.,
Janssen
I.M.C.,
Wahab
P.J.,
Groenen
M.J.M.,
Berends
F.J.
(The
Netherlands)
17:00
O-‐043
Consecutive
178
primary
and
revisional
gastric
bypasses
by
SILS:
feasibility
&
preliminary
results
Chelala
E.,
Estievenart
J.,
Bombeck
C.
(Belgium)
17:10
O-‐044
Uncommon
complications
after
gastric
banding
Margolin
M.,
Margolina
E.
(Latvia)
17:20
O-‐045
Revision
surgery
for
the
failed
or
complicated
gastric
band:
an
Australasian
perspective
Yee
G.,
Jorgensen
J.,
Talbot
M.,
Loi
K.,
Kuzinkovas
V.,
Dillemans
B.,
Ozmen
J.
(Australia)
Hall
300
Bariatric
Surgery
in
Adolescents:
Dutch
Society
for
Metabolic
and
Bariatric
Surgery
16:00-‐17:30
21. 21
Program
in
detail
-‐
Parallel
Sessions
17:35
–
18:35
Copper
Room
Gastric
Bypass
-‐
Match
of
the
day
RNY
Bypass
or
sleeve:
Who
will
become
the
ultimate
survivor
17:35-‐18:35
Moderator:
Raul
Rosenthal
(USA)
17:35
RNY
Gastric
Bypass
or
sleeve:
Who
will
become
the
ultimate
survivor?
17:35
O-‐O46
Early
results
of
the
Swiss
Multicentre
Bypass
Or
Sleeve
Study
(SM-‐BOSS):
a
prospective
randomized
trial
comparing
laparoscopic
sleeve
gastrectomy
and
Roux-‐Y-‐gastric
bypass
Peterli
R.,
Borbély
Y.,
Kern
B.,
Gass
M.,
Peters
T.,
Thurnheer
M.,
Schultes
B.,
Laederach
K.,
Bueter
M.,
Schiesser
M.
(Switzerland)
17:45
RNY
Gastric
Bypass
or
sleeve:
Who
will
become
the
ultimate
survivor?
Moderator:
Raul
Rosenthal
(USA)
Panel
experts:
David
Nocca
(France)
Michel
Gagner
(Canada)
Michel
Suter
(Switzerland)
Dillemans
Bruno
(Belgium)
ARC
Session:
Long-‐Term
Results
17:35-‐18:35
Chairman:
Yuri
Yashkov
(Russia)
Moderators:
Jean
Marc
Gillardin
(Belgium)
17:35
O-‐047
Long-‐term
outcome
of
primary
vertical
banded
gastroplasty
van
Wezenbeek
M.R.,
Smulders
J.F.,
de
Zoete
J.P.J.G.M.,
Luyer
M.D.P.,
van
Montfort
G.,
Nienhuijs
S.W.
(The
Netherlands)
17:45
O-‐048
The
long
magenstrasse
in
the
treatement
of
super
obese
patients
(results
over
5
years
after
surgery)
Vassallo
C.,
Berbiglia
G.
(Italy)
17:55
O-‐049
Long-‐term
nutritional
status
after
Roux-‐en-‐Y
gastric
bypass
in
patients
with
no-‐show
on
regular
follow-‐up
Dogan
K.,
Homan
J.,
Schijns
W.,
Aarts
E.O.,
de
Boer
H.,
van
Laarhoven
C.J.H.M.,
Aufenacker
T.J.,
Janssen
I.M.C.,
Berends
F.J.
(The
Netherlands)
18:05
O-‐050
Five-‐year
weight
loss
in
primary
gastric
bypass
and
revisional
gastric
bypass
for
failed
adjustable
gastric
banding.
Results
of
a
case-‐matched
study
Thereaux
J.,
Corigliano
N.,
Poitou
C.,
Carette
C.,
Beauchet
A.,
Oppert
J-‐M.,
Czernichow
S.,
Bouillot
J-‐L.
(France)
18:15
O-‐051
Five-‐year
results
of
laparoscopic
sleeve
gastrectomy
Peterli
R.,
Sieber
P.,
Wölnerhanssen
B.,
Gass
M.,
Kern
B.,
Slawik
M.,
Peters
T.
(Switzerland)
18:25
O-‐052
Seven-‐year
results
of
sleeve
gastrectomy
22. 22
Catheline
J.M.,
Dbouk
R.,
Kassem
A.,
Bonnel
C.,
Bendacha
Y.,
Cohen
R.
(France)
Hall
300
Session:
Screening
&
Health
Aspects
17:35-‐18:35
Chairman:
tba
Moderators:
tba
17:35
O-‐053
Relationship
between
fat
mass
distribution
and
reported
sleep
disorders
in
patients
preparing
for
bariatric
surgery
Ilovar
A.,
Pintar
T.
(Slovenia)
17:45
O-‐054
Prevalence
of
gastrointestinal
symptoms
and
upper
endoscopic
findings
in
a
population
of
obese
patients
candidate
to
bariatric
surgery:
a
prospective
study
Carabotti
M.,
Liguori
A.,
Ridolfi
M.,
Iossa
A.,
De
Angelis
F.,
Avallone
M.,
Capoccia
D.,
Scirocco
A.,
Leonetti
F.,
Severi
C.,
Silecchia
G.
(Italy)
17:55
O-‐055
Laparoscopic
bariatric
surgery
in
elderly
obese
patients:
to
do
or
not
to
do?
Genser
L.,
Barat
M.,
Tabbara
M.,
Carandina
S.,
Chiheb
S.,
Rizk
N.,
Polliand
C.,
Barrat
C.
(France)
18:05
O-‐056
The
metabolomic
fingerprint
of
obesity
and
bariatric
surgery
Gralka
E.,
Luchinat
C.,
Tenori
L.,
Ernst
B.,
Thurnheer
M.,
Schultes
B.
(Switzerland)
18:15
O-‐057
Prevalence
and
impact
of
dumping
syndrome
on
QOL
after
primary
gastric
bypass
surgery
Emous
M.,
Ubels
F.L.,
Apers
J.A.,
Wolffenbuttel
B.H.R.,
Totté
E.,
van
Beek
A.P.
(The
Netherlands)
18:25
O-‐058
Relationship
of
psychiatric
treatment
to
12-‐month
outcomes
after
gastric
bypass
Shen
S.C.,
Lin
H.Y.,
Yen
Y.C.,
Huang
C.K.,
Chang
P.C.
(Taiwan)
23. 23
FRIDAY
2
MAY
2014
08:00-‐18:00
Registration
&
Information
desk
FRIDAY
2
MAY
2014
08:30-‐10:00
08:30
–
10:00
Overview
Parallel
Sessions
Main
Session:
Sleeve
Gastrectomy
-‐
Part
1
(Copper
Room)
Teaching
(Silver
Room)
Young
IFSO
(ARC)
Plastic
Surgery:
Post-‐Bariatric
Functional
Surgery
(Hall
300)
10:00-‐10:30:
Coffee
break
10:30
–
12:30
Overview
Parallel
Sessions
Main
Session:
Sleeve
Gastrectomy
-‐
Part
2
(Copper
Room)
New
Techniques
in
Bariatric
Surgery
(Silver
Room)
Complications
in
Bariatric
Surgery
(ARC)
Anesthesiology
and
Intensive
Care
in
Obesity
Surgery
(Hall
300)
10:30
–
12:30
Midday
Program
• Selected
ePoster
Presentations
(Exhibition
hall)
• ePoster
Viewing
(Exhibition
hall)
• Corporate
Symposium:
Allergan
(Copper
Room)
• Corporate
Workshop:
WL
Gore
(Room
201)
24. 24
Program
in
detail
-‐
Parallel
Sessions
08:30-‐10:00
Copper
Room
Sleeve
Gastrectomy
-‐
Part
1
08:30-‐10:00
Chairman:
Matthias
Lannoo
(Belgium
Moderators:
Antonio
Torres
Garcia
(Spain),
Konrad
Karcz
(Germany),
Pradeep
Chowbey
(India)
08:30
Sleeve
and
metabolic
syndrome
Christine
Stroh
(Germany)
08:45
Tips
and
tricks,
“How
I
do
a
Sleeve”
Michel
Gagner
(Canada)
09:00
Fast
track
in
bariatric
surgery
Guido
Mannaerts
(The
Netherlands)
09:15
Can
Sleeve
Gastrectomy
defeat
RYGBP
Marco
Bueter
(Switzerland)
09:30
12
years
results
of
Sleeve
Jacques
Himpens
(Belgium)
09:45
Laparoscopic
Magenstrasse
and
Mill
gastroplasty
Arnaud
De
Roover
(Belgium)
Silver
Room
Teaching
08:30-‐10:00
Chairman:
Sanjay
Agrawal
(UK)
Moderators:
Arnaud
De
Roover
(Belgium),
Cynthia
Borg
(UK)
08:30
Centers
of
Excellence:
IFSO
endorsed
CoE
program:
present
&
future
John
Melissas
(Greece)
08:45
–
09:15
Teaching
in
Bariatric
Surgery
08:45
Training
programs
influence
in
the
learning
curve
of
laparoscopic
gastric
bypass
Antonio
Torres
Garcia
(Spain)
09:00
How
to
train
surgical
residents
to
perform
laparoscopic
RNY
gastric
bypass
safely?
Sanjay
Agrawal
(UK)
09:15
Fast-‐track
bariatric
surgery
with
low
complication
rate
and
enhanced
recovery
Hjörtur
Gislason
(Iceland
&
Norway)
09:30
O-‐059
The
patient
requirements
of
an
information
technology
tool
in
bariatric
patient
education
Yong
J.,
Alfallouji
Y.,
Gunasekara
A.,
Srivastava
S.,
Shaath
M.,
Jones
E.,
King
D.,
Purkayastha
S.,
Mobasheri
M.
(UK)
09:40
O-‐060
Performing
qualitative
interviews
with
post-‐operative
patients
can
offer
valuable
insights
into
what
education
we
should
provide
to
new
bariatric
surgery
candidates
Owers
C.E.,
Halliday
V.,
Ackroyd
R.
(UK)
09:50
O-‐061
An
educational
video
for
laparoscopic
gastric
bypass
–
Colour
animation
Bouckaert
W.,
Knol
J.,
Houben
B.,
Sergeant
G.,
DeGols
J.,
Vangertruyden
G.
(Belgium)
25. 25
ARC
Young
IFSO
08:30-‐10:00
Chairman:
Karin
Dolezalova
(Czech
Republic)
Moderators:
Sylvia
Weiner
(Germany),
Jody
Valk
(Belgium),
Ramon
Vilallonga
(Spain)
08:30
O-‐062
Gastric
band
slippage:
the
impact
of
a
change
in
education
and
band
filling
Findlay
L.,
Ball
W.,
Ramus
J.,
Sampson
M.,
Hallworth-‐Cook
K.
(UK)
08:42
O-‐063
LRYGB
and
pregnancy:
a
retrospective
analysis
of
fertility
and
obstetrical
and
neonatal
complications
Ardui
J.,
Gypen
B.,
Hendrickx
L.,
Valk
J.
(Belgium)
08:54
O-‐064
The
value
of
diagnostic
laparoscopy
on
detecting
complications
after
Roux-‐en-‐Y
gastric
bypass
and
sleeve
gastrectomy
S.
Weiner
(Germany)
09:06
O-‐065
Patient´s
pathway
to
a
bariatric
centre
Dolezalova
K.,
Herlesová
J.,
Fried
M.
(Czech
Republic)
09:18
O-‐066
Surgical
management
of
super
obesity:
which
technique
do
i
choose?
Arrue
Del
Cid
E.,
Sánchez
López
E.,
Saez
Carlin
P.,
Estela
L.,Rubio
M.A.,
Torres
García
A.J.,
Cabrerizo
L.,
Sánchez
Pernaute
A.
(Spain)
09:30
O-‐067
Developing
the
optimal
bariatric
operation
table
Aarts
E.O.,
Homan
J.,
Schijns
W.,
Berends
F.J.,
Janssen
I.M.C.
(The
Netherlands)
09:42
O-‐068
Russian
bariatric
surgery
in
2013
-‐
Data
of
the
National
Bariatric
Registry
Khatsiev
B
,
Kuzminov
A.,
Yashkov
Y.
(Russia)
Hall
300
Plastic
Surgery:
Post-‐Bariatric
Functional
Surgery
08:30-‐10:00
Chairman:
Sebastiaan
Van
Cauwenberge
(Belgium)
Moderators:
Clement
Coenen
(Belgium),
Cindy
Lafaire
(Belgium)
08:30
Neck
lift
in
the
post-‐bariatric
patient
Guy
Swennen
(Belgium)
08:45
Breast
lifting
&
breast
prosthesis
after
obesity
surgery
Clement
Coenen
(Belgium)
09:00
Brachioplasty
&
thighplasty
after
massive
weight
loss
Nicolas
Cuylits
(Belgium)
09:15
Lower
body
lift
Cindy
Lafaire
(Belgium)
09.30
Complications
in
post-‐bariatric
surgery
Sebastiaan
Van
Cauwenberge
(Belgium)
09.45
O-‐069
Negative
pressure
treatment
for
improvement
of
surgical
wounds
after
circumferential
thigh
lift:
a
comparison
study
in
post-‐obese
patients
Margara
A.,
Boriani
F.,
Millo
P.,
Allieta
R.
(Italy)
26. 26
Program
in
detail
-‐
Parallel
Sessions
10:30-‐12:30
Copper
Room
Sleeve
Gastrectomy
-‐
Part
2
10:30-‐12:30
Chairman:
Jean
Closset
(Belgium)
Moderators:
Michel
Gagner
(Canada),
David
Nocca
(France),
Guido
Mannaerts
(The
Netherlands)
10:30
Why
does
the
sleeve
not
work
on
everybody?
Sylvia
Weiner
(Germany)
10:50
Prevention
of
weight
regain:
The
smaller
the
better?
Resection
of
the
antrum?
David
Nocca
(France)
11:10
Banded
or
non-‐banded
Sleeve
Konrad
Karcz
(Germany)
In
case
of
failure:
11:30
Re-‐sleeve:
“
Meta
–
analysis
of
Re-‐Sleeve:
On
which
patients
should
we
do
Re-‐
sleeve
and
which
ones
should
have
a
conversion”
Michel
Gagner
(Canada)
11:50
Sadi’s
Antonio
Torres
Garcia
(Spain)
12:05
BPD-‐DS
Rudolf
Weiner
(Germany)
12:15
Gastric
Bypass
Santi
Azagra
(Luxembourg)
Silver
Room
New
Techniques
in
Bariatric
Surgery
10:30-‐12:30
Chairman:
Jean-‐Louis
Allé
(Belgium)
Moderators:
Roberto
Tacchino
(Italy),
Jan
Willem
Greve
(The
Netherlands),
Dennis
Pitot
(Belgium)
10:30
Future
aspects
and
emerging
technologies
in
metabolic
surgery
Jérome
Dargent
(France)
10:42
Cost
effectiveness
of
SILS
approach
in
bariatric
surgery
Roberto
Tacchino
(Italy)
10:54
All
by
SILS
bariatric
surgery:
an
experience
of
more
than
500
patients
Jean
Louis
Allé
(Belgium)
11:06
Advantage
of
the
SILS
approach
in
bariatric
surgery
Praveen
Raj
(India)
11:18
Advantage
of
reduced
port
approach
in
bariatric
surgery
Giovanni
Dapri
(Belgium)
11:30
EndoBarrier.
Where
are
we
in
2014?
Jan
Willem
Greve
(The
Netherlands)
11:42
Robotic
gastric
bypass,
to
be
or
not
to
be
Robert
Caiazzo
(France)
11:54
The
role
of
robotics
on
redo
bariatric
surgery
Carlos
Vaz
(Portugal)
12:06
Time
reduced
surgery
by
new
devices
Martine
Goergen
(Luxembourg)
12:18
Future
perspectives
in
minimally
invasive
surgery
Bernard
Dallemagne
(France)
27. 27
ARC
Complications
in
Bariatric
Surgery
10:30-‐12:30
Chairman:
Shikora
Scott
(USA)
Moderators:
Keseva
Mannur
(UK),
Nasser
Sakran
(Israel),
Leo
Hendrickx
(Belgium)
10:30
Principles
of
revisional
surgery
Henri
Buchwald
(USA)
10:45
Salvage
bypass
after
early
sleeve
leaks-‐A
new
option
in
acute
leaks
Mahendra
Narwaria
(India)
11:00
How
to
treat
an
eroded
AGB
by
SILS?
Kristel
De
Vogelaere
(Belgium)
11:15
O-‐070
Prognostication
of
complications
after
Roux
en
Y
gastric
bypass:
evaluation
of
the
OS-‐
MRS
and
the
Clavien-‐Dindo
classification
Coblijn
U.K.,
de
Castro
S.M.M.
Lagarde
S.M.,
van
Tets
W.F.,
de
Wit
L.Th.,
van
Wagensveld
B.A.
(The
Netherlands)
11:27
O-‐071
Internal
hernia
after
laparoscopic
Roux-‐en-‐Y
gastric
bypass:
a
correlation
between
radiological
and
operative
findings
Goudsmedt
F.,
Deylgat
B.,
Dillemans
B.
(Belgium)
11:39
O-‐072
Revisional
surgery
for
intractable
dumping
syndrome
after
laparoscopic
Roux-‐en-‐Y
gastric
bypass
–
A
Case
Series
Po-‐Chih
C.,
Chih-‐Kun
H.,
Kirubakaran
M.,
Chi-‐Ming
T.,
Ming-‐Che
H.(Taiwan)
11:51
O-‐073
Combined
laparoscopic-‐endoscopic
assisted
T-‐tube
insertion
for
the
management
of
post-‐laparoscopic
sleeve
gastrectomy
leak
Barreca
M.,
Nagliati
C,
Whitelaw
D.,
Jambulingam
P.,
Jain
V.
(UK)
12:03
O-‐074
Does
gastric
leaks
have
an
impact
on
weight
loss
and
satisfaction
rate
after
sleeve
gastrectomy:
a
case-‐matched
study?
Rebibo
L.,
Dhahri
A.,
Verhaeghe
P.,
Cosse
C.,
Regimbeau
J-‐M.
(France)
12:15
O-‐075
Hyperammonemic
encephalopathy
complicating
bariatric
surgery:
A
case
study
and
review
of
the
literature
Estrella
J.,
Yee
G.,
Wilcken
B.,
Talbot
M.,
Tan
M.,
Ozmen
J.
(Australia)
Hall
300
Anesthesiology
and
Intensive
Care
in
Obesity
Surgery
10:30-‐12:30
Chairman:
Jan
Mulier
(Belgium)
Moderator:
Mike
Margarson
(UK)
10:30-‐11:10
What
you
should
know
as
a
surgeon
to
help
improve
the
anesthesia
delivery
for
your
bariatric
patients
10:30
Pre
operative
information
that
anesthesiologists
need.
Is
active
diagnostic
screening
for
OSAS
needed?
Paolo
Pelosi
(Italy)
10:50
What
is
highest
risk
for
surgery,
when
to
delay
surgery
?
Place
for
pre-‐operative
weight
reduction
and
why
Mike
Margarson
(UK)
28. 28
11:10
-‐
11:30
What
you
should
know
as
an
anaesthesiologist
to
help
improve
the
bariatric
surgical
outcome
11:10
Deep
NMB
and
optimizing
laparoscopic
workspace
for
your
surgeon,
post-‐operative
bleeding
prevention
and
efficient
per-‐operative
leak
test
Jan
Mulier
(Belgium)
11:30
-‐
12:10
What
should
you
know
as
an
anaesthesiologist
to
improve
your
anaesthesia
outcome
11:30
What
is
the
ideal
anti-‐trombotic
and
antibiotic
dose
in
morbid
obese
patients
coming
for
bariatric
surgery?
Debaerdemaker
Luc
(Belgium)
11:50
Impact
of
anaesthesia
without
opioids
in
morbid
obese
patients
in
reducing
obstructive
breathing,
aspiration
and
post-‐operative
pain
Jan
Mulier
(Belgium)
12:10
O-‐076
Oral
administration
of
corticosteroids
is
as
effective
as
injection
in
alleviating
postoperative
nausea
after
laparoscopic
gastric
bypass
Nordin
L.,
Nordlund
A.,
Vilstrup
C.,
Gislason
H.,
Hedenbro
J.
(Sweden)
12:20
Panel
Discussion
29. 29
Program
in
detail
-‐
Midday
Program
12:30-‐14:00
Copper
Room
Corporate
Symposium:
Allergan
12:35-‐14:00
Room
201
Corporate
Workshop:
WL
Gore
12:35-‐14:00
Exhibition
Hall
Selected
ePoster
Presentations
II
12:45-‐13:50
Chairman:
Marc
Legrand
(Belgium)
Each
presentation
will
take
5
minutes
1
P29
Gastric
plication
versus
sleeve:
700
cases
none
randomized
study
Fardoun
A.
(United
Arab
Emirates)
2
P34
Weight
patterns
in
morbid
obesity
after
laparoscopic
sleeve
gastrectomy
and
Roux-‐en-‐
Y
gastric
bypass
Sabench
F.,
Molina
A.,
Hernández
M.,
Blanco
S.,
Sánchez
A.,
Piñana
M.L.,
Raga
E.,
París
M.,
Muñoz
A.,
Del
Castillo
D.
(Spain)
3
P38
Nutritional
deficiencies
after
Scopinaro
and
biliopancreatic
diversion
with
duodenal
switch
surgery
for
morbid
obesity
Homan
J.,
Betzel
B.,
van
Wageningen
B.,
Aarts
E.O.,
Janssen
I.G.M.,
Berends
F.J.
(The
Netherlands)
4
P55
Sleeved
gastric
bypass
–
The
consensual
operation
Ribeiro
R.,
Guerra
A.,
Manaças
L.,
Pereira
J.
(Portugal)
5
P56
Preoperative
fasting
protects
aged
obese
mice
against
renal
ischemia-‐reperfusion
injury
Jongbloed
F.,
de
Bruin
R.W.F.,
van
den
Engel
S.,
van
der
Laan
L.J.W.,
van
Steeg
H.,
IJzermans
J.N.M.,
Dollé
M.E.T.
(The
Netherlands)
6
P61
Failed
sleeve
gastrectomy:
Roux-‐en-‐Y
gastric
bypass
or
duodenal
switch?
Homan
J.,
Betzel
B.,
Aarts
E.O.,
van
Laarhoven
C.J.M.,
Janssen
I.G.M.,
Berends
F.J.
(The
Netherlands)
7
P62
Revisional
gastric
bypass
after
primary
bariatric
surgery
failure
–
Long-‐term
results
from
a
single
centre
Panomarenco
T.,
Loi
P.,
Mehdi
A.,
Barea
M.
Closset
J.
(Belgium)
8
P63
Laparoscopic
conversion
of
a
failed
isolated
sleeve
gastrectomy
to
a
biliopancreatic
diversion
with
duodenal
switch
or
a
Roux-‐en-‐Y
gastric
bypass
Carmeli
I.,
Golomb
I.,
Sadot
E.,
Kashtan
H.,
Keidar
A.
(Israel)
9
P67
Sleeve
gastrectomy
as
a
salvage
procedure
for
failed
primary
bariatric
restrictive
surgeries
Mofti
A.
(Saudi
Arabia)
10
P74
Can
gambling
habits
and
impulse
control
be
used
to
predictor
of
weight
loss
in
bariatric
patients?
30. 30
Kulendran
M.,
Lim M., Vlaev
I.,
Wingfield
L.R.,
Scholtz
S.,
Purkayastha
S.,
Darzi
A.
(UK)
11
P78
The
safety
and
efficiency
of
a
fast-‐track
protocol
in
gastric
sleeve
surgery
Vreeswijk
S.J.M.,
Van
Rutte
P.,
Nienhuijs
S.W.,
Bouwman
R.A.,
Smulders
J.F.,
Buise
M.P.
(The
Netherlands)
12
P82
Mechanisms
of
sleeve-‐gastrectomy
efficiency:
only
gastrorestriction?
Todurov
I.,
Bilianskyi
L.,
Perekhrestenko
O.,
Kalashnikov
O.,
Kosiukhno
S.,
Plehutsa
O.,
Razdobudko
Y.
(Ukraine)
13
P83
Laparoscopic
sleeve
gastrectomy
in
children
and
adolescents:
the
technique
and
the
standardized
peri-‐operative
clinical
pathway
Alqahtani
A.,
Elahmedi
M.
(Saudi
Arabia)
14
P86
Impact
of
sleeve
gastrectomy
on
pre
and
postprandrial
ghrelin
plasma
levels:
long
term
results
Kapiris
S.,
Patrikakos
P.,
Perrea
D.,
Mauromatis
T.
(Greece)
31. 31
FRIDAY
2
MAY
2014
14:00-‐18:30
14:00
–
15:30
Overview
Parallel
Sessions
Main
Session:
Metabolic
Surgery
-‐
Part
1:
Diabetes
(Copper
Room)
Gastric
Bypass:
Nordic
Experience
and
Research
-‐
Part
1
(Silver
Room)
Omega
Loop
Gastric
Bypass
(ARC)
Health
&
Economics
(Hall
300)
15:30-‐16:00:
General
Assembly
IFSO-‐EC
(Copper
Room)
Coffee
break
16:00
–
17:30
Overview
Parallel
Sessions
Main
Session:
Metabolic
Surgery
-‐
Part
2:
Hot
Issues
(Copper
Room)
Gastric
Bypass:
Nordic
Experience
and
Research
-‐
Part
2
(Silver
Room)
Gastric
Plication
(ARC)
Challenging
Situations
in
Bariatric
Surgery
(Hall
300)
17:35
–
18:35
Overview
Parallel
Sessions
Video
session:
It
Happened
nearby:
Disasters
in
Bariatric
Surgery
(Copper
Room)
Session:
Metabolic
Surgery
(Silver
Room)
Session:
Gastric
bypass
and
related
techniques
(ARC)
Session:
Gastric
bypass:
Miscellaneous
(Hall
300)
20:00
Farewell
dinner
32. 32
Program
in
detail
-‐
Parallel
Sessions
14:00
–
15:45
Copper
Room
Metabolic
Surgery
-‐
Part
1
14:00-‐15:45
Chairman:
François
Pattou
(France)
Moderators:
Andrei
Keidar
(Israel),
Michel
Prager
(Austria),
Yves
Van
Nieuwenhove
(Belgium)
14:00
Intensive
medical
therapy
and
long
term
outcomes
for
obese
diabetes
2
patients
Bart
Van
der
Schueren
(Belgium)
14:15
Perioperative
glucose
control
in
patients
with
diabetes
Anders
Thorell
(Sweden)
14:30
Prediction
of
DM
remission
after
bariatric
surgery
by
measuring
C-‐peptide
level
Edo
Aarts
(The
Netherlands)
14:45
Poor
rate
of
remission
of
DM
type
2
after
bariatric
surgery
in
severe
diabetes
Andrei
Keidar
(Israel)
15:00
Outcome
of
metabolic
surgery
in
patients
>60
year
Yves
Van
Nieuwenhove
(Belgium)
15:15
Reduced
cardiovascular
risks
after
Bariatric
Surgery
Ramon
Villalonga
(Spain)
15:30
Long
term
relapse
after
initial
remission
of
DM
François
Pattou
(France)
Silver
Room
Gastric
Bypass:
Nordic
Experience
and
Research
-‐
Part
1
14:00-‐15:30
Chairman:
Hjörtur
Gislason
(Iceland
&
Norway)
Co-‐chairmen:
Peter
Funch-‐Jensen
(Denmark),
Mikael
Wirén
(Sweden)
14:00
Introduction
Hjörtur
Gislason
(Iceland
&
Norway)
14:05
The
SOREG
database:
system
buildup
and
QoL
data
in
28000
patients
Erik
Näslund
(Sweden)
14:20
The
Lönroth
technique
for
gastric
bypass
with
long-‐term
results
Hjörtur
Gislason
(Iceland
&
Norway)
14:35
Gastric
bypass
in
adolescents-‐5
year
experience
form
a
Swedish
nationwide
controlled
study
Torsten
Olbers
(Sweden)
14:50
Revisional
surgery:
VBG/AGB
=>
GBP
and
GBP
=>
BPD/DS
Bent
Johnny
Nergard
(Norway)
15:05
Small
intestinal
adaptation:
results
from
a
RCT
in
superobesity
Jan
Hedenbro
(Sweden)
`
33. 33
ARC
Omega
Loop
Gastric
Bypass
14:00-‐15:30
Chairman:
Jacques
Himpens
(Belgium)
Moderator:
Chevallier
Jean-‐Marc
(France),
Ruijs
Ribeiro
(Portugal)
14:00
Introduction
Jacques
Himpens
(Belgium)
14:05
Place
of
the
"omega
loop"
bypass
amidst
the
other
techniques
in
a
busy
bariatric
unit
Rudolf
Weiner
(Germany)
14:20
O-‐077
Omega
or
mini-‐gastric
bypass
for
morbid
obesity
in
France:
report
of
the
first
1000
cases
followed
up
to
7
years
Chevallier
J.M.,
Guenzi
M.,
Bruzzi
M.,
Rau
C.,
Arman
G.,
Zinzindohoué
F.,
Berger
A
.
(France)
14:30
How
to
avoid
biliary
reflux
in
Omega
Loop
GB:
is
it
an
issue?
Manuel
Garciacaballero
(Spain)
14:45
Does
Omega
Loop
bypass
behave
differently
from
RYGB
in
terms
of
glucose
metabolism?
Jacques
Himpens
(Belgium)
15:00
O-‐078
Incidence,
presentation
and
management
of
enteric
leaks
after
Omega
loop
gastric
bypass
Genser
L.,
Soprani
A.,
Sibaud
O.,
Torcivia
A.,
Godfroy
J.,
Siksik
J.M.,
Hannoun
L.,
Cady
J.
(France)
15:10
Panel
discussion:
Do
the
benefits
of
omega
loop
gastric
bypass
outweigh
the
(potential)
drawbacks?
Panel
members:
Rudolf
Weiner
(Germany),
Manuel
Garciacaballero
(Spain),
Chevallier
Jean-‐Marc
(France),
Jacques
Himpens
(Belgium),
Antoine
Soprani
(France)
Hall
300
Health
&
Economics
14:00-‐15:30
Chairman:
Alberic
Fiennes
(UK)
Moderators:
Marco
Bueter
(Switzerland),
Anne
Juuti
(Finland),
Jean
Saey
(Belgium)
14:00
Economics
of
metabolic
surgery
Martin
Neovius
(Sweden)
14:15
Cost–utility
of
bariatric
surgery
for
morbid
obesity
in
Finland
Anne
Juuti
(Finland)
14:30
Responses
to
bariatric
surgery:
"role
of
our
(other)
genome"
Karine
Clement
(France)
15:00
Cybermedicine
in
FU
Juan
Pujol-‐Rafols
(Spain)
15:15
Perioperative
safety
prevents
postoperative
complications
Henri
Buchwald
(USA)
34. 34
Program
in
detail
-‐
Parallel
Sessions
16:00
–
17:30
Copper
Room
Metabolic
Surgery
-‐
Part
2:
Hot
Issues
16:15-‐17:30
Chairman:
Nicola
Scopinaro
(Italy)
Moderator:
Martine
Goergen
(Luxembourg),
Gerhard
Prager
(Austria),
Surendra
Ugale
(India)
16:15
Metabolic
surgery
in
BMI<35
Nicola
Scopinaro
(Italy
)
16:30
Glucose
metabolism
3
years
after
RY
versus
Omega
Gastric
Bypass
Jacques
Himpens
(Belgium)
16:45
Bile
acids
after
bariatric
surgery.
The
new
gut
hormones?
Dimitri
Pournaras
(UK)
17:00
Sensory,
reward
and
physiological
domain
changes
of
taste
after
gastric
bypass
Marco
Bueter
(Switzerland)
17:15
Metabolic
effects
of
ileal
transposition
Alper
Çelik
(Turkey)
Silver
Room
Gastric
Bypass:
Nordic
Experience
and
Research
-‐
Part
2
16:00-‐17:30
Chairman:
Hjörtur
Gislason
(Iceland
&
Norway)
Co-‐chairmen:
Peter
Funch-‐Jensen
(Denmark),
Mikael
Wirén
(Sweden)
16:00
Randomised
trial
of
closing
vs
not-‐closing
mesenteric
defects,
a
SOREG
study
Erik
Näslund
(Sweden)
16:15
Closing
the
mesenterial
defects
with
staplers
to
prevent
internal
hernia;
5000
GBP
Hjörtur
Gislason
(Iceland
&
Norway)
16:30
Short
term
complications
in
28
000
patients
Erik
Stenberg
(Sweden)
16:45
Aggressive
surgical
strategy
to
deal
with
anastomotic
leaks,
experience
of
6030
bypasses
Sven
Fredriksen
(Sweden)
17:00
Why
do
patients
lose
weight
and
maintain
weight
loss
after
gastric
bypass?
Torsten
Olbers
(Sweden)
17:15
Conclusion
Peter
Funch-‐Jensen
(Denmark)